3M Agrees to $7.35 Billion Settlement Over Forever Chemicals Personal Injury Claims
The industrial conglomerate will resolve thousands of lawsuits regarding PFAS exposure over nine years.
1Massive Legal Settlement Reached
Industrial conglomerate 3M has agreed to pay $7.35 billion to settle personal injury claims linked to PFAS exposure. This agreement addresses approximately 99% of current lawsuits, including those within the Aqueous Film-Forming Foam Multi-District Litigation. Between 115,000 and 120,000 plaintiffs are eligible to participate in this significant legal resolution.
2No Admission of Liability
Despite the multi-billion dollar commitment, 3M explicitly stated that it does not admit liability for the alleged health damages. The company maintains its readiness to defend against future litigation. CEO William Brown characterized the deal as a milestone that substantially reduces the uncertainty surrounding these ongoing legal challenges.
3Payment Structure and Timeline
The settlement funds will be distributed over a nine-year period. Payments begin with $50 million in 2026, with no disbursements scheduled for 2027. Starting in 2028, 3M will pay over $1 billion annually through 2033. Approximately 20% of the total settlement amount is allocated for the final two years.
4Health Risks of PFAS
PFAS, known as forever chemicals, are manufactured substances used for heat, stain, and water resistance. Exposure is linked to severe health issues, including kidney and testicular cancer, liver damage, and reduced antibody responses to vaccines. These chemicals are highly persistent in the environment, creating long-term public health and safety concerns.
5Context of Previous Settlements
This agreement follows a separate $10.3 billion settlement reached by 3M in 2023. That previous deal resolved claims from U.S. public water systems regarding drinking water contamination. Combined, these settlements represent a massive financial commitment by the company to address the widespread environmental and health impacts of its chemical products.
6Industry-Wide Legal Scrutiny
3M is not the only company facing legal pressure regarding PFAS contamination. Other major chemical manufacturers, including DuPont, Corteva, and Chemours, are currently dealing with similar lawsuits. The growing volume of litigation highlights the significant financial and legal exposure for corporations involved in the production of these persistent industrial substances.
7Strategic Shift in Manufacturing
As litigation intensifies, 3M has officially completed its plan to discontinue the global manufacture of all PFAS substances by the end of 2025. This move marks a major shift in the company's industrial operations, reflecting the increasing regulatory and public pressure surrounding the use of these specific chemical compounds.
8Future Litigation Risks Remain
While this settlement covers current claims, 3M notes that future personal injury cases will be handled through separate mechanisms. The company retains the option to cancel the current agreement if insufficient plaintiffs participate. For victims, the settlement provides necessary support for mounting medical bills and costs incurred over the last decade.